List of Myriad Women's Health, Inc. patents

List of Myriad Women's Health, Inc. patents

List of Oncimmune patents

List of Biodesix patents

List of Skyhawk Therapeutics patents

Companies in the Computer industry

List of funding rounds for MOLOCO

Patents where

Current Assignee

Name

is

Myriad Women's Health, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11993811 Systems and methods for identifying and quantifying gene copy number variations	Patent 11993811 was granted and assigned to Myriad Women's Health, Inc. on May, 2024 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11993811	May 28, 2024
	‌ US Patent 11326158 Enrichment of cell-free DNA from a biological sample		Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11326158	May 10, 2022
	‌ US Patent 11527304 Systems and methods for inferring genetic ancestry from low-coverage genomic data	Patent 11527304 was granted and assigned to Myriad Women's Health, Inc. on December, 2022 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11527304	December 13, 2022
	‌ US Patent 11932910 Combinatorial DNA screening	Patent 11932910 was granted and assigned to Myriad Women's Health, Inc. on March, 2024 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11932910	March 19, 2024
	‌ US Patent 11339431 Methods and compositions for enrichment of target polynucleotides	Patent 11339431 was granted and assigned to Myriad Women's Health, Inc. on May, 2022 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11339431	May 24, 2022
	‌ US Patent 10597717 Combinatorial DNA screening	Patent 10597717 was granted and assigned to Myriad Women's Health, Inc. on March, 2020 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	10597717	March 24, 2020
	‌ US Patent 10968447 Methods and compositions for enrichment of target polynucleotides	Patent 10968447 was granted and assigned to Myriad Women's Health, Inc. on April, 2021 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	10968447	April 6, 2021
	‌ US Patent 10752946 Methods and compositions for enrichment of target polynucleotides		Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	10752946	August 25, 2020
	‌ US Patent 11016110 Reagent delivery and waste management system	Patent 11016110 was granted and assigned to Myriad Women's Health, Inc. on May, 2021 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11016110	May 25, 2021
	‌ US Patent 10497463 Automated nucleic acid repeat count calling methods	Patent 10497463 was granted and assigned to Myriad Women's Health, Inc. on December, 2019 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	10497463	December 3, 2019
	‌ US Patent 12020779 Noninvasive prenatal screening using dynamic iterative depth optimization with depth-scaled variance determination	Patent 12020779 was granted and assigned to Myriad Women's Health, Inc. on June, 2024 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	12020779	June 25, 2024
	‌ US Patent 11975330 Devices for handling laboratory plates and methods of using the same	Patent 11975330 was granted and assigned to Myriad Women's Health, Inc. on May, 2024 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11975330	May 7, 2024
	‌ US Patent 12104212 Personalized methods for detecting circulating tumor DNA	Patent 12104212 was granted and assigned to Myriad Women's Health, Inc. on October, 2024 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	12104212	October 1, 2024
	‌ US Patent 11708574 Nucleic acid sequencing adapters and uses thereof		Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11708574	July 25, 2023
	‌ US Patent 11854666 Noninvasive prenatal screening using dynamic iterative depth optimization	Patent 11854666 was granted and assigned to Myriad Women's Health, Inc. on December, 2023 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	11854666	December 26, 2023
	‌ US Patent 12024749 Combinatorial DNA screening	Patent 12024749 was granted and assigned to Myriad Women's Health, Inc. on July, 2024 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	12024749	July 2, 2024
	‌ US Patent 12080383 Automated nucleic acid repeat count calling methods	Patent 12080383 was granted and assigned to Myriad Women's Health, Inc. on September, 2024 by the United States Patent and Trademark Office.	Myriad Women's Health, Inc.	Myriad Women's Health, Inc.		United States Patent and Trademark Office	12080383	September 3, 2024

17 results

0 selected

17 results

0 selected